Hein W. Verspaget

21.9k total citations
236 papers, 9.7k citations indexed

About

Hein W. Verspaget is a scholar working on Oncology, Surgery and Genetics. According to data from OpenAlex, Hein W. Verspaget has authored 236 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 64 papers in Surgery and 57 papers in Genetics. Recurrent topics in Hein W. Verspaget's work include Inflammatory Bowel Disease (56 papers), Protease and Inhibitor Mechanisms (31 papers) and Peptidase Inhibition and Analysis (24 papers). Hein W. Verspaget is often cited by papers focused on Inflammatory Bowel Disease (56 papers), Protease and Inhibitor Mechanisms (31 papers) and Peptidase Inhibition and Analysis (24 papers). Hein W. Verspaget collaborates with scholars based in Netherlands, United States and Germany. Hein W. Verspaget's co-authors include C. B. H. W. Lamers, Laurens Kruidenier, Cornelis F.M. Sier, W. van Duijn, Daniël W. Hommes, R. A. van Hogezand, Ineke Kuiper, Lukas J.A.C. Hawinkels, Cornelis Bhw Lamers and Jan H. Verheijen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and Gastroenterology.

In The Last Decade

Hein W. Verspaget

234 papers receiving 9.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hein W. Verspaget Netherlands 53 3.1k 2.1k 2.0k 1.9k 1.7k 236 9.7k
Yoshiro Niitsu Japan 48 3.8k 1.2× 1.9k 0.9× 1.3k 0.6× 818 0.4× 761 0.4× 290 8.9k
Isao Okayasu Japan 51 4.6k 1.5× 3.0k 1.5× 2.5k 1.3× 2.2k 1.2× 1.2k 0.7× 310 11.8k
Yatrik M. Shah United States 57 5.1k 1.6× 1.7k 0.8× 1.0k 0.5× 935 0.5× 2.8k 1.6× 171 10.4k
Andrzej S. Tarnawski United States 55 3.5k 1.1× 1.4k 0.7× 3.9k 1.9× 1.1k 0.6× 1.2k 0.7× 237 10.8k
Giuliano Ramadori Germany 59 3.1k 1.0× 1.4k 0.7× 2.7k 1.3× 666 0.4× 760 0.4× 375 12.3k
Rebecca Taub United States 63 6.4k 2.0× 2.2k 1.1× 3.9k 1.9× 1.4k 0.8× 1.3k 0.8× 165 15.6k
Masahiko Tsujii Japan 45 2.8k 0.9× 2.0k 1.0× 2.9k 1.4× 3.4k 1.8× 1.8k 1.1× 198 11.6k
D Stern United States 57 4.9k 1.6× 796 0.4× 1.4k 0.7× 903 0.5× 1.5k 0.9× 92 16.6k
Hitoshi Yoshiji Japan 50 3.7k 1.2× 2.2k 1.1× 1.4k 0.7× 591 0.3× 2.3k 1.4× 365 10.9k
Efstratios Patsouris Greece 49 3.2k 1.0× 2.5k 1.2× 1.6k 0.8× 555 0.3× 1.5k 0.9× 385 9.0k

Countries citing papers authored by Hein W. Verspaget

Since Specialization
Citations

This map shows the geographic impact of Hein W. Verspaget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hein W. Verspaget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hein W. Verspaget more than expected).

Fields of papers citing papers by Hein W. Verspaget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hein W. Verspaget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hein W. Verspaget. The network helps show where Hein W. Verspaget may publish in the future.

Co-authorship network of co-authors of Hein W. Verspaget

This figure shows the co-authorship network connecting the top 25 collaborators of Hein W. Verspaget. A scholar is included among the top collaborators of Hein W. Verspaget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hein W. Verspaget. Hein W. Verspaget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnhoorn, Marieke C., Hein W. Verspaget, Károly Szuhai, et al.. (2023). Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis. JCI Insight. 8(9). 7 indexed citations
2.
Baunwall, Simon Mark Dahl, Nicolas Benech, Gianluca Ianiro, et al.. (2023). Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology. 16. 1108339261–1108339261. 15 indexed citations
3.
Borgers, Jessica S.W., Elisabeth M. Terveer, Monique E. van Leerdam, et al.. (2022). Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial. BMC Cancer. 22(1). 1366–1366. 18 indexed citations
4.
Kerbert, Annarein, Enric Reverter, Miguel Navasa, et al.. (2018). Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates. Clinical Transplantation. 32(11). e13412–e13412. 9 indexed citations
5.
Shi, Xiaolei, Cornelia J. Verhoeven, Jeroen Dubbeld, et al.. (2017). Donor‐specific anti‐HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation. Clinical Transplantation. 32(2). 17 indexed citations
6.
Wasser, Martin N.J.M., François E.J.A. Willemssen, Marianne de Vries, et al.. (2015). Value of Magnetic Resonance Cholangiopancreatography in Assessment of Nonanastomotic Biliary Strictures After Liver Transplantation. Transplantation Direct. 1(10). e42–e42. 9 indexed citations
7.
Duijvestein, Marjolijn, Ilse Molendijk, Helene Roelofs, et al.. (2011). Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy. 13(9). 1066–1073. 40 indexed citations
8.
Hove, W. Rogier ten, Sanna op den Dries, Bart van Hoek, et al.. (2011). Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver International. 31(8). 1110–1117. 15 indexed citations
9.
Dihal, Ashwin A., Carina L. Bos, Philip W. Voorneveld, et al.. (2011). 5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. Gut. 61(12). 1708–1715. 27 indexed citations
10.
Hawinkels, Lukas J.A.C., Patricia Kuiper, Eliza Wiercinska, et al.. (2010). Matrix Metalloproteinase-14 (MT1-MMP)–Mediated Endoglin Shedding Inhibits Tumor Angiogenesis. Cancer Research. 70(10). 4141–4150. 219 indexed citations
11.
Jorissen, Robert N., Lara Lipton, Peter Gibbs, et al.. (2008). DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers. Clinical Cancer Research. 14(24). 8061–8069. 75 indexed citations
12.
Kubben, F J G M, Cornelis F.M. Sier, Lukas J.A.C. Hawinkels, et al.. (2007). Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. European Journal of Cancer. 43(12). 1869–1876. 128 indexed citations
13.
Hawinkels, Lukas J.A.C., Hein W. Verspaget, W. van Duijn, et al.. (2007). Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients. British Journal of Cancer. 97(3). 398–404. 72 indexed citations
14.
Verspaget, Hein W., et al.. (1996). Gastric mucosal superoxide dismutases in Helicobacter pylori infection.. Gut. 38(4). 502–506. 37 indexed citations
15.
Smitt, Peter A.E. Sillevis, Theo Mulder, Hein W. Verspaget, et al.. (1994). Metallothionein in Amyotrophic Lateral Sclerosis. Neurosignals. 3(4). 193–197. 46 indexed citations
16.
Sier, Cornelis F.M., Hein W. Verspaget, G Griffioen, et al.. (1993). Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.. Gut. 34(1). 80–85. 52 indexed citations
17.
Arndt, J. W., et al.. (1990). Value of Indium-Ill Tropolonate Autologous Granulocyte Scintigraphy in the Assessment of Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology. 25(sup178). 93–98. 13 indexed citations
18.
Arndt, J. W., Hein W. Verspaget, D. Blok, et al.. (1989). Image quality and radiopharmaceutical parameters of Indium-111 granulocytes in scintigraphy of inflammatory bowel disease. European Journal of Nuclear Medicine and Molecular Imaging. 15(4). 197–200. 6 indexed citations
19.
Peña, A. S., I. Biemond, Hein W. Verspaget, et al.. (1989). Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?. Gut. 30(9). 1236–1240. 61 indexed citations
20.
Verspaget, Hein W., A. S. Peña, Irene T. Weterman, & C. B. H. W. Lamers. (1988). Disordered regulation of the in vitro immunoglobulin synthesis by intestinal mononuclear cells in Crohn's disease.. Gut. 29(4). 503–510. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026